We are live on ! Find out more
CLYM

Climb Bio
CLYM

69 hedge funds and large institutions have $61.9M invested in Climb Bio in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less capital invested

Capital invested by funds: $63.4M → $61.9M (-$1.5M)

3.13% less ownership

Funds ownership: 76.97% → 73.83% (-3.1%)

9% less funds holding

Funds holding: 76 → 69 (-7)

17% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 23

27% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 26

Holders
69
Holders Change
-7
Holders Change %
-9.21%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
19
Reduced
23
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$626K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$604K
3
NFT
Nan Fung Trinity
Hong Kong
+$577K
4
Millennium Management
Millennium Management
New York
+$519K
5
SC
Shay Capital
New York
+$268K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.77M
2
NFGH
Nan Fung Group Holdings
Hong Kong
-$566K
3
SSA
Schonfeld Strategic Advisors
New York
-$540K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$451K
5
State Street
State Street
Massachusetts
-$343K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$39M – – –
CF
2
Cantor Fitzgerald
New York
$3.1M +$626K +503,116 +25%
Citigroup
3
Citigroup
New York
$2M -$296K -238,231 -13%
AAA
4
Affinity Asset Advisors
New York
$1.86M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.65M -$213K -171,306 -11%
DTC
6
Deep Track Capital
Connecticut
$1.29M – – –
KCM
7
Kynam Capital Management
New Jersey
$1.28M -$23.2K -18,659 -2%
TCM
8
Tang Capital Management
California
$1.24M – – –
BlackRock
9
BlackRock
New York
$1.09M -$1.77M -1,418,455 -62%
DP
10
Diadema Partners
New Jersey
$871K +$40.2K +32,332 +5%
PLC
11
Peapod Lane Capital
New York
$689K +$2.3K +1,851 +0.3%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$680K -$47K -37,763 -6%
Renaissance Technologies
13
Renaissance Technologies
New York
$614K -$23.5K -18,898 -4%
Alyeska Investment Group
14
Alyeska Investment Group
Illinois
$602K +$604K +485,364 New
Millennium Management
15
Millennium Management
New York
$595K +$519K +416,699 +657%
NFT
16
Nan Fung Trinity
Hong Kong
$575K +$577K +463,654 New
SC
17
Shay Capital
New York
$515K +$268K +215,000 +108%
UBS Group
18
UBS Group
Switzerland
$474K +$320 +257 +0.1%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$387K -$451K -362,090 -54%
JP Morgan Chase
20
JP Morgan Chase
New York
$261K -$120K -96,302 -31%
SFM
21
Sphera Funds Management
Israel
$260K -$39.9K -32,098 -13%
Goldman Sachs
22
Goldman Sachs
New York
$250K +$100K +80,570 +67%
Two Sigma Investments
23
Two Sigma Investments
New York
$223K -$94K -75,523 -30%
Jane Street
24
Jane Street
New York
$184K +$184K +148,180 New
PAP
25
Persistent Asset Partners
Hong Kong
$180K -$723 -581 -0.4%
1
2 3 4

CLYM Hedge Fund Activity: Q2 2025 in Review

69 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q2 2025, worth a combined $61.9M — down 2.4% from $63.4M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of CLYM and 19 opened new positions — a net loss of 7 holders — while 23 trimmed existing stakes and 19 added.

The largest buyer was Cantor Fitzgerald, adding an estimated $626K. The largest seller was BlackRock, cutting an estimated $1.77M.

  • 69 institutional investors held Climb Bio (CLYM) as of Q2 2025, down from 76 in Q1 2025.
  • Funds reported $61.9M of Climb Bio stock for Q2 2025, down 2.4% quarter-over-quarter.
  • 19 funds opened new Climb Bio positions in Q2 2025 and 26 closed out, a net change of -7 holders.
  • The largest Climb Bio buyer in Q2 2025 was Cantor Fitzgerald, an estimated $626K added.
  • The largest Climb Bio seller in Q2 2025 was BlackRock, an estimated $1.77M sold.

Based on aggregated 13F filings for Q2 2025.